{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:13:51Z","timestamp":1791504831434,"version":"4.3.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Monomorphic posttransplant lymphoproliferative disorders have been defined as lymphoid or plasmacytic proliferations that fulfill criteria for one of the B-cell or T\/NK-cell neoplasms recognized in immunocompetent hosts in the current WHO Classification. Low-grade B-cell neoplasms have historically been excluded from this category, although rare reports of marginal zone lymphoma (MZL) have been described. We report 9 cases of posttransplant Epstein-Barr virus-negative MZL, all arising in solid organ transplant recipients (4 renal, 3 liver, 1 cardiac, and 1 liver, pancreas, and small bowel). Seven were extranodal MZL of mucosa-associated lymphoid tissue type, all of which had gastrointestinal involvement (4 colon, 1 duodenum, 1 stomach, and 1 oropharynx\/base of tongue). Notably, the preferential involvement of intestine distinguishes posttransplant extranodal MZL from sporadic cases. Immunoglobulin light-chain restriction was seen in all cases, with polymerase chain reaction showing a monoclonal pattern in 7 of 8 cases with successful amplification of polymerase chain reaction products. A clonally unrelated recurrence was seen in one case. Next-generation sequencing identified recurrent mutations previously reported in MZL in 3\/5 cases. MZL was diagnosed at least 1 year after solid organ transplant (median time to presentation, 84\u2009mo; range, 13 to 108\u2009mo). The median age was 44 (range, 9 to 73\u2009y); the male: female ratio was 5:4. The mean follow-up was 33.4 months, with an indolent clinical course observed. A subset responded to reduction in immunosuppression and anti-CD20 therapy alone. These data support the designation of Epstein-Barr virus-negative MZL as an uncommon form of monomorphic posttransplant lymphoproliferative disorders.<\/jats:p>","DOI":"10.1097\/pas.0000000000001514","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:48:56Z","timestamp":1592394536000},"page":"1340-1352","source":"Crossref","is-referenced-by-count":14,"title":["Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder"],"prefix":"10.1097","volume":"44","author":[{"given":"Pallavi","family":"Galera","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Flavin","sequence":"additional","affiliation":[{"name":"Hematopathology Service, Trinity St. James\u2019s Cancer Institute, St. James\u2019s Hospital and Trinity College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematology& Hematopathology, Medical College of Georgia at Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Saksena","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyou","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-You","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego Health System, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Swan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, St. Vincent\u2019s University Hospital, and UCD School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder","volume":"15","author":"Luskin","year":"2015","journal-title":"Am J Transplant"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial","year":"2005","journal-title":"J Clin Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","article-title":"Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Leblond","year":"2001","journal-title":"J Clin Oncol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?","volume":"24","author":"Nelson","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post-organ transplant hematologic cancers","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?","volume":"35","author":"Gibson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/PAS.0000000000001113","article-title":"Expanding the spectrum of EBV-positive marginal zone lymphomas: a lesion associated with diverse immunodeficiency settings","volume":"42","author":"Gong","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-09-1220","article-title":"Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients","volume":"19","author":"Quinlan","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2559.1996.292338.x","article-title":"Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients","volume":"28","author":"Wotherspoon","year":"1996","journal-title":"Histopathology"},{"key":"R16-20230922","first-page":"530","article-title":"Regression of a gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori in a kidney graft recipient","volume":"107","author":"Le Meur","year":"1999","journal-title":"Am J Med"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00000478-200001000-00012","article-title":"Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients","volume":"24","author":"Hsi","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/00007890-200104270-00027","article-title":"Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients","volume":"71","author":"Shehab","year":"2001","journal-title":"Transplantation"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.TP.0000040875.50963.2C","article-title":"MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature","volume":"75","author":"Aull","year":"2003","journal-title":"Transplantation"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1053-2498(01)00423-5","article-title":"Regression of gastric lymphoma of mucosa associated with lymphoid tissue (MALT) following cardiac transplantation","volume":"21","author":"Boissonnat","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4274\/Tjh.2012.0010","article-title":"Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center","volume":"31","author":"Bakanay","year":"2014","journal-title":"Turk J Haematol"},{"key":"R22-20230922","first-page":"26","article-title":"Outcome of rapamycin therapy for post-transplant-lymphoproliferative disorder after kidney transplantation: case series","volume":"9","author":"Ashrafi","year":"2015","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2014a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R25-20230922","first-page":"74","article-title":"Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation\u2014a rare post-transplant lymphoma?","volume":"10","author":"Chaffin","year":"2017","journal-title":"Hum Pathol (N Y)"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/cncr.32136","article-title":"Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014","volume":"125","author":"Noone","year":"2019","journal-title":"Cancer"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.V85.5.1396.bloodjournal8551396","article-title":"Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus","volume":"85","author":"Frank","year":"1995","journal-title":"Blood"},{"key":"R28-20230922","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/TP.0000000000002146","article-title":"The changing epidemiology of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients over 30 years: a single-center experience","volume":"102","author":"Peters","year":"2018","journal-title":"Transplantation"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00595-008-3981-6","article-title":"Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: report of a case","volume":"39","author":"Kim","year":"2009","journal-title":"Surg Today"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","article-title":"Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)","volume":"5","author":"Oertel","year":"2005","journal-title":"Am J Transplant"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/lt.21921","article-title":"Multiple pulmonary mucosa-associated lymphoid tissue lymphomas after living donor liver transplantation","volume":"15","author":"Shoji","year":"2009","journal-title":"Liver Transpl"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.0303-6987.2005.00363.x","article-title":"Epstein-Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin","volume":"32","author":"Verma","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcp\/aqx134","article-title":"Epstein-Barr Virus-positive extranodal marginal zone lymphoma of bronchial-associated lymphoid tissue in the posttransplant setting: an immunodeficiency-related (posttransplant) lymphoproliferative disorder?","volume":"149","author":"Cassidy","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3109\/10428194.2015.1113282","article-title":"Donor-derived marginal zone lymphoma following reduced-intensity allogeneic peripheral blood stem cell transplant","volume":"57","author":"Sundararajan","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ajcp\/aqw216","article-title":"B-Cell and classical Hodgkin lymphomas associated with immunodeficiency: 2015 SH\/EAHP Workshop Report-Part 2","volume":"147","author":"de Jong","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.amjms.2016.04.011","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma: posttransplant lymphopoliferative disorder","volume":"352","author":"Tu","year":"2016","journal-title":"Am J Med Sci"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaapos.2017.10.016","article-title":"Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant","volume":"22","author":"Bata","year":"2018","journal-title":"J aapos"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.leu.2401708","article-title":"Lack of CD95\/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas","volume":"14","author":"Bertoni","year":"2000","journal-title":"Leukemia"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: from morphology to molecules","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/ajt.13558","article-title":"EBV-positive and EBV-negative posttransplant diffuse large B cell lymphomas have distinct genomic and transcriptomic features","volume":"16","author":"Ferreiro","year":"2016","journal-title":"Am J Transplant"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1547691X.2013.798388","article-title":"Immunomodulation and lymphoma in humans","volume":"11","author":"Ponce","year":"2014","journal-title":"J Immunotoxicol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Morscio","year":"2013","journal-title":"Am J Transplant"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1097\/TP.0000000000001025","article-title":"HLA and risk of diffuse large B cell lymphoma after solid organ transplantation","volume":"100","author":"Hussain","year":"2016","journal-title":"Transplantation"},{"key":"R48-20230922","first-page":"e2009018","article-title":"Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease","volume":"1","author":"Capello","year":"2009","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Manez","year":"1997","journal-title":"J Infect Dis"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/01.pas.0000213317.59176.d2","article-title":"Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study","volume":"30","author":"Johnson","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2012-06-438549","article-title":"Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis","volume":"121","author":"Perry","year":"2013","journal-title":"Blood"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:59:14Z","timestamp":1695423554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001514","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,16]]}}}